Call your doctor before leaving home if you think you’ve been exposed to COVID-19 or have symptoms

Due to the presence of COVID-19 in our community, visitor restrictions are in place for all Duke clinics and hospitals. For your safety and the safety of others, we recommend patients do not bring a visitor to Duke clinics, if at all possible. If a visitor must accompany a patient, only one individual over 12 years of age is allowed. Patients and visitors will be screened for symptoms upon arrival. Individuals with flu-like symptoms are not allowed. View the complete list of Visitor Restrictions.

Effective immediately, Duke Health is prioritizing and rescheduling some non-emergent or non-critical surgeries, procedures, and appointments. Check our COVID-19 (Coronavirus) page for updates.

FREEDOM-1 - Clinical Trial

What is the Purpose of this Study?

We are doing this study to learn about the benefits the study drug (FCR001) may have compared to standard medicine in kidney transplants.
What is the Condition Being Studied?
Kidney Transplant

Who Can Participate in the Study?

- Adults 18-60
- Never had a kidney transplant

You cannot participate in this study if you are:
- Pregnant or nursing
- Have HIV
- Have Hepatitis B or C

Age Group

What is Involved?

If you choose to join this study you will:
- Be randomized (like flipping a coin) to Group 1 or group 2:
-- Group 1 will:
- Receive the study drug (FCR001) which is a a stem cell-based medicine
- Apheresis (a way to filter blood and get stem cells)
- Start conditioning medicine 4 days before transplant surgery
- Complete about 20 visits over 5 years
- Get kidney biopsies

--Group 2 will:
- Get standard care
- Complete about 20 visits over 5 years
- Get kidney biopsies

Study Details

Full Title
A randomized, controlled, multi-center, safety and efficacy study of FCR001 cell-based therapy relative to a tacrolimus and mycophenolate-based regimen in de novo living donor renal transplant recipients, and safety in FCR001 donors (the FREEDOM-1 study)
Principal Investigator
Kidney/Pancreas Transplant Surgeon
Protocol Number
IRB: PRO00103135
NCT: NCT03995901
Phase III
Contact the Duke Recruitment Innovation Center